Skip to content
RushPR News – Lifestyle
Author:
Scynexis
SCYNEXIS Announces One-for-Eight Reverse Stock Split
May 22, 2026
SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 11, 2026
SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 6, 2026
SCYNEXIS Announces $40.0 Million Private Placement
March 31, 2026
SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
March 31, 2026